Prospects for Moxidectin as a New Oral Treatment for Human Scabies

PLoS Negl Trop Dis. 2016 Mar 17;10(3):e0004389. doi: 10.1371/journal.pntd.0004389. eCollection 2016 Mar.

Kate E Mounsey^{1

2}, Charlotte Bernigaud³, Olivier Chosidow^{3

4}, James S McCarthy^{2

5}

¹ Inflammation & Healing Research Cluster, School of Health and Sport Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia.
² Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
³ Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.
⁴ Université Paris-est Créteil Val de Marne, Créteil, France.
⁵ School of Medicine, University of Queensland, Herston, Queensland, Australia.

No abstract available

MeSH terms

The authors received no specific funding for this work.